disputerer for ph.d.-graden i helsevitenskap og vil offentlig forsvare avhandlingen:
“Antibiotic Resistance in Oral Streptococci: The prevalence, diversity, stability, and fitness cost of Tn916 -Tn1545 family in oral streptococcal isolates”
Avhandlingen er tilgjengelig her! Auditoriet er åpent for publikum. Både prøveforelesing og disputas vil i tillegg bli strømmet. Prøveforelesning over oppgitt emne holdes kl. 10.15, samme sted:
Direktelenke prøveforelesning/ Direktelenke Disputas. |
Populærvitenskapelig sammendrag av avhandlingen:
Streptococci, the most abundant species in the mouth, can share DNA via mobile genetic elements like Tn916-Tn1545 family elements.
Tn916, the prototype of this family carries the tetracycline resistance genes and can move by “cutting” itself from the host, forming a Circular Intermediate (CI) and “pasting” the replicated copies into the host and recipient’s genome. In the first study, a rapid and reliable digital droplet PCR (ddPCR) assay that determines the copy number and CI numbers of Tn916 was established.
In the second study we observed high transfer frequencies among these clinical isolates despite the low CI levels and illustrates that the low concentrations of tetracycline, the donor, the recipient, and the number of CI can influence the transfer rates. Furthermore, we report that 21% of the clinical oral streptococcal isolates in our study carried one copy of Tn916.
The third study revealed that introducing Tn916 into a naïve host imposes a biological cost that can be ameliorated with 500 generations and that the element is stable in the absence of tetracycline for up to 1000 generations. Taken together, the prevalence and diversity, stability, and rapid reduction in fitness cost, can, in part explain the continued increase of tetracycline resistance among oral streptococci populations.
Hovedveileder
Instituttleder Mohammed Al-Haroni, Institutt for klinisk odontologi, Det helsevitenskapelige fakultet, UiT Norges arktiske universitet.
Biveiledere
Professor Pål Jarle Johnsen, Institutt for farmasi, Det helsevitenskapelige fakultet, UiT Norges arktiske universitet.
Bedømmelseskomité
Professor Nagihan Bostanci, Karolinska Institutet - 1. opponent.
Førsteamanuensis Roger Junges, UiO - 2. opponent.
Førsteamanuensis Napat Limchaichana Bolstad, Institutt for klinisk odontologi, Det helsevitenskapelige fakultet, UiT Norges arktiske universitet – leder av komité.
Disputasleder
Førsteamanuensis Linda Stein, Institutt for klinisk odontologi, Det helsevitenskapelige fakultet, UiT Norges arktiske universitet.